<?xml version="1.0" encoding="UTF-8"?>
  	<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url>
      <loc>https://www.ajmc.com/view/innovation-is-outpacing-reimbursement-health-system-execs-warn</loc><lastmod>2026-07-15T19:56:37.724Z</lastmod><news:news><news:publication_date>2026-07-15T19:56:37.724Z</news:publication_date>
        <news:title><![CDATA[Innovation Is Outpacing Reimbursement, Health System Execs Warn]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/respiratory-rehabilitation-benefits-patients-with-copd-and-suspected-ph</loc><lastmod>2026-07-15T17:49:46.757Z</lastmod><news:news><news:publication_date>2026-07-15T17:49:46.757Z</news:publication_date>
        <news:title><![CDATA[Respiratory Rehabilitation Benefits Patients With COPD and Suspected PH]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/kerry-rogers-md-talks-btk-inhibitor-sequencing-cost-access-in-cll</loc><lastmod>2026-07-15T15:42:39.937Z</lastmod><news:news><news:publication_date>2026-07-15T15:42:39.937Z</news:publication_date>
        <news:title><![CDATA[Kerry Rogers, MD, Talks BTK Inhibitor Sequencing, Cost, Access in CLL]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/fda-approves-gedatolisib-for-hr-her2--advanced-breast-cancer</loc><lastmod>2026-07-15T15:34:34.148Z</lastmod><news:news><news:publication_date>2026-07-15T15:34:34.148Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Gedatolisib for HR+/HER2- Advanced Breast Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/new-agents-aim-to-close-gaps-in-chronic-hand-eczema-care</loc><lastmod>2026-07-15T15:18:01.323Z</lastmod><news:news><news:publication_date>2026-07-15T15:18:01.323Z</news:publication_date>
        <news:title><![CDATA[New Agents Aim to Close Gaps in Chronic Hand Eczema Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/leah-szumita-msn-nurse-navigators-widen-access-to-clinical-trials</loc><lastmod>2026-07-15T15:15:18.272Z</lastmod><news:news><news:publication_date>2026-07-15T15:15:18.272Z</news:publication_date>
        <news:title><![CDATA[Leah Szumita, MSN: Nurse Navigators Widen Access to Clinical Trials]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/cvi-range-assessment-validated-as-reliable-measure-of-functional-vision-in-children</loc><lastmod>2026-07-15T14:00:00Z</lastmod><news:news><news:publication_date>2026-07-15T14:00:00Z</news:publication_date>
        <news:title><![CDATA[CVI Range Assessment Validated as Reliable Measure of Functional Vision in Children]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/ms-likely-unfolds-along-a-continuum-years-before-first-symptoms</loc><lastmod>2026-07-15T13:30:00Z</lastmod><news:news><news:publication_date>2026-07-15T13:30:00Z</news:publication_date>
        <news:title><![CDATA[MS Likely Unfolds Along a Continuum Years Before First Symptoms]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/bispecific-sequencing-crs-risk-and-celmods-navigating-the-evolving-second-line-rrmm-landscape</loc><lastmod>2026-07-15T12:05:00Z</lastmod><news:news><news:publication_date>2026-07-15T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Bispecific Sequencing, CRS Risk, and CELMoDs: Navigating the Evolving Second-Line RRMM Landscape]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/physician-choice-and-step-therapy-in-retinal-vascular-diseases</loc><lastmod>2026-07-15T12:05:00Z</lastmod><news:news><news:publication_date>2026-07-15T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Physician Choice and Step Therapy in Retinal Vascular Diseases]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/role-of-prior-authorization-in-accessing-anti-vegf-therapies-in-retinal-vascular-diseases</loc><lastmod>2026-07-15T12:00:00Z</lastmod><news:news><news:publication_date>2026-07-15T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Role of Prior Authorization in Accessing Anti-VEGF Therapies in Retinal Vascular Diseases]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/teclistamab-plus-daratumumab-majestec-3-data-patient-selection-and-the-evolving-role-of-bispecifics-in-rrmm</loc><lastmod>2026-07-15T12:00:00Z</lastmod><news:news><news:publication_date>2026-07-15T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Teclistamab Plus Daratumumab: MajesTEC-3 Data, Patient Selection, and the Evolving Role of Bispecifics in RRMM]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/provider-trust-social-media-use-can-shape-vaccine-myth-belief</loc><lastmod>2026-07-14T21:14:27.625Z</lastmod><news:news><news:publication_date>2026-07-14T21:14:27.625Z</news:publication_date>
        <news:title><![CDATA[Provider Trust, Social Media Use Can Shape Vaccine Myth Belief]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/medicaid-fraud-crackdown-intensifies-but-is-it-solving-the-right-problem-</loc><lastmod>2026-07-14T21:00:00Z</lastmod><news:news><news:publication_date>2026-07-14T21:00:00Z</news:publication_date>
        <news:title><![CDATA[Medicaid Fraud Crackdown Intensifies, But Is It Solving the Right Problem?]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/nyc-legionnaires-disease-cluster-slows-as-cooling-tower-remediation-continues</loc><lastmod>2026-07-14T20:40:26.132Z</lastmod><news:news><news:publication_date>2026-07-14T20:40:26.132Z</news:publication_date>
        <news:title><![CDATA[NYC Legionnaires Disease Cluster Slows as Cooling Tower Remediation Continues]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/female-newborns-more-likely-to-miss-vitamin-k-prophylaxis-hepatitis-b-birth-dose</loc><lastmod>2026-07-14T19:30:11.563Z</lastmod><news:news><news:publication_date>2026-07-14T19:30:11.563Z</news:publication_date>
        <news:title><![CDATA[Female Newborns More Likely to Miss Vitamin K Prophylaxis, Hepatitis B Birth Dose]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/closing-language-access-gaps-is-key-to-improving-financial-assistance-awareness-erin-l-duffy-phd-mph</loc><lastmod>2026-07-14T19:00:00Z</lastmod><news:news><news:publication_date>2026-07-14T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Closing Language Access Gaps Is Key to Improving Financial Assistance Awareness: Erin L. Duffy, PhD, MPH]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/fda-approved-at-home-sc-lecanemab-initiation-dose-for-early-alzheimer-disease</loc><lastmod>2026-07-14T18:55:01.802Z</lastmod><news:news><news:publication_date>2026-07-14T18:55:01.802Z</news:publication_date>
        <news:title><![CDATA[FDA Approved At-Home SC Lecanemab Initiation Dose for Early Alzheimer Disease]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/reducing-pediatric-cancer-financial-toxicity-requires-support-beyond-treatment-cherie-daly-md</loc><lastmod>2026-07-14T16:00:00Z</lastmod><news:news><news:publication_date>2026-07-14T16:00:00Z</news:publication_date>
        <news:title><![CDATA[Reducing Pediatric Cancer Financial Toxicity Requires Support Beyond Treatment: Cherie Daly, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/veligrotug-approval-expands-treatment-options-for-thyroid-eye-disease-michael-yen-md</loc><lastmod>2026-07-14T14:30:00Z</lastmod><news:news><news:publication_date>2026-07-14T14:30:00Z</news:publication_date>
        <news:title><![CDATA[Veligrotug Approval Expands Treatment Options for Thyroid Eye Disease: Michael Yen, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/new-survey-highlights-quality-of-life-benefits-of-dry-eye-disease-treatment</loc><lastmod>2026-07-13T21:00:43.179Z</lastmod><news:news><news:publication_date>2026-07-13T21:00:43.179Z</news:publication_date>
        <news:title><![CDATA[New Survey Highlights Quality-of-Life Benefits of Dry Eye Disease Treatment]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/jak-inhibitors-reshaped-alopecia-areata-care-but-long-term-data-gaps-remain</loc><lastmod>2026-07-13T21:00:41.215Z</lastmod><news:news><news:publication_date>2026-07-13T21:00:41.215Z</news:publication_date>
        <news:title><![CDATA[JAK Inhibitors Reshaped Alopecia Areata Care, but Long-Term Data Gaps Remain]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/risk-stratification-drives-cellular-therapy-recommendations-for-mcl-in-the-btk-inhibitor-era</loc><lastmod>2026-07-13T20:38:00Z</lastmod><news:news><news:publication_date>2026-07-13T20:38:00Z</news:publication_date>
        <news:title><![CDATA[Risk Stratification Drives Cellular Therapy Recommendations for MCL in the BTK Inhibitor Era]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/the-state-of-the-sarcoma-treatment-landscape-alexander-spira-md-phd-facp-fasco</loc><lastmod>2026-07-13T20:30:12.212Z</lastmod><news:news><news:publication_date>2026-07-13T20:30:12.212Z</news:publication_date>
        <news:title><![CDATA[The State of the Sarcoma Treatment Landscape: Alexander Spira, MD, PhD, FACP, FASCO ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/biologics-appear-renal-safe-in-psoriasis-il-17-agents-show-kidney-promise</loc><lastmod>2026-07-13T20:15:22.139Z</lastmod><news:news><news:publication_date>2026-07-13T20:15:22.139Z</news:publication_date>
        <news:title><![CDATA[Biologics Appear Renal-Safe in Psoriasis, IL-17 Agents Show Kidney Promise]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/team-based-telehealth-model-matches-in-person-care-for-atopic-dermatitis</loc><lastmod>2026-07-13T19:53:26.460Z</lastmod><news:news><news:publication_date>2026-07-13T19:53:26.460Z</news:publication_date>
        <news:title><![CDATA[Team-Based Telehealth Model Matches In-Person Care for Atopic Dermatitis]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/tackling-racial-disparities-in-aml-care-karilyn-larkin-md</loc><lastmod>2026-07-13T19:49:58.314Z</lastmod><news:news><news:publication_date>2026-07-13T19:49:58.314Z</news:publication_date>
        <news:title><![CDATA[Tackling Racial Disparities in AML Care: Karilyn Larkin, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/comprehensive-smoke-free-laws-linked-to-sustained-drop-in-cvd-mortality</loc><lastmod>2026-07-13T19:46:03.116Z</lastmod><news:news><news:publication_date>2026-07-13T19:46:03.116Z</news:publication_date>
        <news:title><![CDATA[Comprehensive Smoke-Free Laws Linked to Sustained Drop in CVD Mortality]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/hf-drug-withdrawal-after-af-ablation-shows-mixed-safety-signals</loc><lastmod>2026-07-13T18:53:57.747Z</lastmod><news:news><news:publication_date>2026-07-13T18:53:57.747Z</news:publication_date>
        <news:title><![CDATA[HF Drug Withdrawal After AF Ablation Shows Mixed Safety Signals]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/ma-linked-to-similar-cancer-treatment-use-lower-anticipated-costs-vs-traditional-medicare</loc><lastmod>2026-07-13T18:52:55.508Z</lastmod><news:news><news:publication_date>2026-07-13T18:52:55.508Z</news:publication_date>
        <news:title><![CDATA[MA Linked to Similar Cancer Treatment Use, Lower Anticipated Costs vs Traditional Medicare]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/biomarker-testing-helps-guide-lung-cancer-therapy-selection-stefanie-houseknecht-pharmd</loc><lastmod>2026-07-13T18:46:00Z</lastmod><news:news><news:publication_date>2026-07-13T18:46:00Z</news:publication_date>
        <news:title><![CDATA[Biomarker Testing Helps Guide Lung Cancer Therapy Selection: Stefanie Houseknecht, PharmD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/ajay-k-nooka-md-mph-on-majestec-3-data-dropping-dexamethasone-in-mm</loc><lastmod>2026-07-13T18:30:00Z</lastmod><news:news><news:publication_date>2026-07-13T18:30:00Z</news:publication_date>
        <news:title><![CDATA[Ajay K. Nooka, MD, MPH, on MajesTEC-3 Data, Dropping Dexamethasone in MM]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/new-retina-mechanisms-beyond-anti-vegf-excite-the-field-paul-hahn-md</loc><lastmod>2026-07-13T17:29:56.610Z</lastmod><news:news><news:publication_date>2026-07-13T17:29:56.610Z</news:publication_date>
        <news:title><![CDATA[New Retina Mechanisms Beyond Anti-VEGF Excite the Field: Paul Hahn, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/car-t-cell-therapy-in-2026-evolving-evidence-expanding-indications-path-to-broader-access</loc><lastmod>2026-07-13T17:23:12.040Z</lastmod><news:news><news:publication_date>2026-07-13T17:23:12.040Z</news:publication_date>
        <news:title><![CDATA[CAR T-Cell Therapy in 2026 and Beyond: Evolving Evidence, Expanding Indications, and the Path to Broader Access ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/policy-changes-faster-testing-turnaround-needed-to-improve-precision-lung-cancer-care-access-robert-kratzke-md</loc><lastmod>2026-07-13T17:00:00Z</lastmod><news:news><news:publication_date>2026-07-13T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Policy Changes, Faster Testing Turnaround Needed to Improve Precision Lung Cancer Care Access: Robert Kratzke, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/barriers-practices-and-the-road-ahead-for-car-t-cell-therapy-in-the-community-setting-michael-byrne-article</loc><lastmod>2026-07-13T15:43:00Z</lastmod><news:news><news:publication_date>2026-07-13T15:43:00Z</news:publication_date>
        <news:title><![CDATA[Barriers, Practices, and the Road Ahead for CAR T-Cell Therapy in the Community Setting: A Q&A With Michael Byrne, DO]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/expanding-car-t-cell-therapy-access-and-building-community-programs-with-robert-richards</loc><lastmod>2026-07-13T15:11:00Z</lastmod><news:news><news:publication_date>2026-07-13T15:11:00Z</news:publication_date>
        <news:title><![CDATA[Expanding CAR T-Cell Therapy Access and Building Community Programs: A Q&A With Robert Richards, MS, MBA]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/community-oncology-and-car-t-cell-therapy-with-lucio-gordan-article</loc><lastmod>2026-07-13T14:43:00Z</lastmod><news:news><news:publication_date>2026-07-13T14:43:00Z</news:publication_date>
        <news:title><![CDATA[Community Oncology and CAR T-Cell Therapy: A Q&A With Lucio Gordan, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/emerging-data-and-the-future-treatment-landscape-in-extrapulmonary-neuroendocrine-carcinoma-novel-therapies-algorithms-and-combination-strategies</loc><lastmod>2026-07-13T12:05:00Z</lastmod><news:news><news:publication_date>2026-07-13T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Emerging Data and the Future Treatment Landscape in Extrapulmonary Neuroendocrine Carcinoma: Novel Therapies, Algorithms, and Combination Strategies]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/unmet-needs-and-emerging-mechanisms-of-action-in-extrapulmonary-neuroendocrine-carcinoma-the-path-toward-better-therapies</loc><lastmod>2026-07-13T12:00:00Z</lastmod><news:news><news:publication_date>2026-07-13T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Unmet Needs and Emerging Mechanisms of Action in Extrapulmonary Neuroendocrine Carcinoma: The Path Toward Better Therapies]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/inca033989-may-address-unmet-need-in-mutant-calreticulin-myelofibrosis-claire-harrison-md</loc><lastmod>2026-07-12T13:00:00Z</lastmod><news:news><news:publication_date>2026-07-12T13:00:00Z</news:publication_date>
        <news:title><![CDATA[INCA033989 May Address Unmet Need in Mutant Calreticulin Myelofibrosis: Claire Harrison, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/kerry-rogers-md-on-btk-inhibitor-selection-and-tolerability-in-cll</loc><lastmod>2026-07-11T14:00:00Z</lastmod><news:news><news:publication_date>2026-07-11T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Kerry Rogers, MD, on BTK Inhibitor Selection and Tolerability in CLL]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/does-bmi-have-prognostic-value-in-dlbcl-a-review-finds-mixed-results</loc><lastmod>2026-07-10T23:38:00Z</lastmod><news:news><news:publication_date>2026-07-10T23:38:00Z</news:publication_date>
        <news:title><![CDATA[Does BMI Have Prognostic Value in DLBCL? A Review Finds Mixed Results]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/fda-expands-perioperative-pembrolizumab-enfortumab-vedotin-regimen-to-all-patients-with-muscle-invasive-bladder-cancer</loc><lastmod>2026-07-10T19:28:19.178Z</lastmod><news:news><news:publication_date>2026-07-10T19:28:19.178Z</news:publication_date>
        <news:title><![CDATA[FDA Expands Pembrolizumab-Enfortumab for Muscle-Invasive Bladder Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/michigan-cyclospora-outbreak-surpasses-1500-cases-as-investigation-continues</loc><lastmod>2026-07-10T19:14:28.913Z</lastmod><news:news><news:publication_date>2026-07-10T19:14:28.913Z</news:publication_date>
        <news:title><![CDATA[Michigan Cyclospora Outbreak Surpasses 1500 Cases as Investigation Continues]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/ai-chatbots-score-below-28-on-colorectal-cancer-questions</loc><lastmod>2026-07-10T18:50:10.684Z</lastmod><news:news><news:publication_date>2026-07-10T18:50:10.684Z</news:publication_date>
        <news:title><![CDATA[AI Chatbots Score Below 28% on Colorectal Cancer Questions]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/multidisciplinary-collaboration-advances-breast-cancer-care-jennifer-sheng-md</loc><lastmod>2026-07-10T17:30:00Z</lastmod><news:news><news:publication_date>2026-07-10T17:30:00Z</news:publication_date>
        <news:title><![CDATA[Multidisciplinary Collaboration Advances Breast Cancer Care: Jennifer Sheng, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/health-equity-access-weekly-roundup-july-10-2026</loc><lastmod>2026-07-10T17:11:13Z</lastmod><news:news><news:publication_date>2026-07-10T17:11:13Z</news:publication_date>
        <news:title><![CDATA[Health Equity & Access Weekly Roundup: July 10, 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/setmelanotide-cuts-bmi-hunger-in-phase-3-trial-for-hypothalamic-obesity</loc><lastmod>2026-07-10T17:00:00Z</lastmod><news:news><news:publication_date>2026-07-10T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Setmelanotide Cuts BMI, Hunger in Phase 3 Trial for Hypothalamic Obesity]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/pharmacists-help-navigate-precision-lung-cancer-care-stefanie-houseknecht-pharmd</loc><lastmod>2026-07-10T16:20:00Z</lastmod><news:news><news:publication_date>2026-07-10T16:20:00Z</news:publication_date>
        <news:title><![CDATA[Pharmacists Help Navigate Precision Lung Cancer Care: Stefanie Houseknecht, PharmD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/stem-cell-engineering-reveals-new-clues-to-rebuilding-beta-cells</loc><lastmod>2026-07-10T16:00:00Z</lastmod><news:news><news:publication_date>2026-07-10T16:00:00Z</news:publication_date>
        <news:title><![CDATA[Stem Cell Engineering Reveals New Clues to Rebuilding Beta Cells]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/reply-to-letter-regarding-preventive-dental-care-and-overall-medical-expenditures-</loc><lastmod>2026-07-10T16:00:00Z</lastmod><news:news><news:publication_date>2026-07-10T16:00:00Z</news:publication_date>
        <news:title><![CDATA[Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/risk-stratification-and-weight-loss-as-therapy-a-hepatologist-s-framework-for-managing-mash-progression</loc><lastmod>2026-07-10T15:55:00Z</lastmod><news:news><news:publication_date>2026-07-10T15:55:00Z</news:publication_date>
        <news:title><![CDATA[Risk Stratification and Weight Loss as Therapy: A Hepatologist's Framework for Managing MASH Progression]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/new-research-points-to-ways-to-shield-beta-cells-from-damage</loc><lastmod>2026-07-10T15:52:00Z</lastmod><news:news><news:publication_date>2026-07-10T15:52:00Z</news:publication_date>
        <news:title><![CDATA[New Research Points to Ways to Shield Beta Cells From Damage]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/screening-mash-upstream-building-a-practical-scalable-algorithm-for-the-real-world</loc><lastmod>2026-07-10T15:50:00Z</lastmod><news:news><news:publication_date>2026-07-10T15:50:00Z</news:publication_date>
        <news:title><![CDATA[Screening MASH Upstream: Building a Practical, Scalable Algorithm for the Real World]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/5-notable-fda-approvals-from-the-first-half-of-2026</loc><lastmod>2026-07-10T15:50:00Z</lastmod><news:news><news:publication_date>2026-07-10T15:50:00Z</news:publication_date>
        <news:title><![CDATA[5 Notable FDA Approvals From the First Half of 2026 ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/on-body-injector-for-sanofi-s-isatuximab-approved-by-fda-upping-anti-cd38-competition-in-myeloma</loc><lastmod>2026-07-11T15:14:00.000Z</lastmod><news:news><news:publication_date>2026-07-10T13:59:00Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Isatuximab On-Body Injector, Raising Anti-CD38 Competition in Myeloma]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/ajmc-in-the-press-july-10-2026</loc><lastmod>2026-07-10T13:00:00Z</lastmod><news:news><news:publication_date>2026-07-10T13:00:00Z</news:publication_date>
        <news:title><![CDATA[AJMC® in the Press, July 10, 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/hr-positive-breast-cancer-integration-of-genomic-testing-and-multidisciplinary-decision-making</loc><lastmod>2026-07-10T12:05:00Z</lastmod><news:news><news:publication_date>2026-07-10T12:05:00Z</news:publication_date>
        <news:title><![CDATA[HR-Positive Breast Cancer: Integration of Genomic Testing and Multidisciplinary Decision-Making]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/hr-positive-breast-cancer-interpreting-ctdna-dynamics-and-clinical-benefit-in-serena-6</loc><lastmod>2026-07-10T12:00:00Z</lastmod><news:news><news:publication_date>2026-07-10T12:00:00Z</news:publication_date>
        <news:title><![CDATA[HR-Positive Breast Cancer: Interpreting ctDNA Dynamics and Clinical Benefit in SERENA-6]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/abbreviated-dapt-cuts-bleeding-without-raising-ischemic-risk-in-high-risk-pci</loc><lastmod>2026-07-09T21:24:31.640Z</lastmod><news:news><news:publication_date>2026-07-09T21:24:31.640Z</news:publication_date>
        <news:title><![CDATA[Abbreviated DAPT Cuts Bleeding Without Raising Ischemic Risk in High-Risk PCI]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/covid-19-medicare-spending-falls-after-acute-infection</loc><lastmod>2026-07-09T21:00:00Z</lastmod><news:news><news:publication_date>2026-07-09T21:00:00Z</news:publication_date>
        <news:title><![CDATA[COVID-19 Medicare Spending Falls After Acute Infection]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/upcoming-2026-fda-decisions-could-expand-treatment-options-across-oncology-and-hepatitis-b</loc><lastmod>2026-07-09T20:55:33.866Z</lastmod><news:news><news:publication_date>2026-07-09T20:55:33.866Z</news:publication_date>
        <news:title><![CDATA[Upcoming 2026 FDA Decisions Could Expand Treatment Options Across Oncology and Hepatitis B]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/consistent-follow-up-strengthens-breast-cancer-survivorship-care-jennifer-sheng-md</loc><lastmod>2026-07-09T20:45:39.009Z</lastmod><news:news><news:publication_date>2026-07-09T20:45:39.009Z</news:publication_date>
        <news:title><![CDATA[Consistent Follow-Up Strengthens Breast Cancer Survivorship Care: Jennifer Sheng, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/pediatric-cancer-creates-long-term-financial-challenges-for-patients-families-cherie-daly-md</loc><lastmod>2026-07-09T19:47:30.472Z</lastmod><news:news><news:publication_date>2026-07-09T19:47:30.472Z</news:publication_date>
        <news:title><![CDATA[Pediatric Cancer Creates Long-Term Financial Challenges for Patients, Families: Cherie Daly, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/axatilimab-has-no-bone-safety-concerns-in-cgvhd-amandeep-salhotra-md</loc><lastmod>2026-07-09T19:30:00Z</lastmod><news:news><news:publication_date>2026-07-09T19:30:00Z</news:publication_date>
        <news:title><![CDATA[Axatilimab Has No Bone Safety Concerns in cGVHD: Amandeep Salhotra, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/contributor-the-role-of-benchmarking-and-interoperability-in-detecting-fraud-waste-and-abuse</loc><lastmod>2026-07-09T18:43:00Z</lastmod><news:news><news:publication_date>2026-07-09T18:43:00Z</news:publication_date>
        <news:title><![CDATA[Contributor: The Role of Benchmarking and Interoperability in Detecting Fraud, Waste, and Abuse]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/changes-in-semaglutide-fills-following-expanded-fda-and-medicare-policies</loc><lastmod>2026-07-09T16:00:00Z</lastmod><news:news><news:publication_date>2026-07-09T16:00:00Z</news:publication_date>
        <news:title><![CDATA[Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/the-future-of-myeloma-treatment-ajai-chari-md</loc><lastmod>2026-07-09T14:30:00Z</lastmod><news:news><news:publication_date>2026-07-09T14:30:00Z</news:publication_date>
        <news:title><![CDATA[The Future of Myeloma Treatment: Ajai Chari, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/optimizing-biomarker-testing-to-guide-early-stage-nsclc-treatment-robert-kratzke-md</loc><lastmod>2026-07-09T13:30:00Z</lastmod><news:news><news:publication_date>2026-07-09T13:30:00Z</news:publication_date>
        <news:title><![CDATA[Optimizing Biomarker Testing to Guide Early-Stage NSCLC Treatment: Robert Kratzke, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/upper-payment-limit-implementation-risks-for-patients-pharmacies-and-providers</loc><lastmod>2026-07-09T13:00:00Z</lastmod><news:news><news:publication_date>2026-07-09T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/closing-the-communication-gap-patient-centered-care-and-clinical-trial-integration-in-rrfl</loc><lastmod>2026-07-09T12:05:00Z</lastmod><news:news><news:publication_date>2026-07-09T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Closing the Communication Gap: Patient-Centered Care and Clinical Trial Integration in RRFL]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/living-with-follicular-lymphoma-counseling-patients-evolving-treatments-and-remaining-unmet-needs</loc><lastmod>2026-07-09T12:00:00Z</lastmod><news:news><news:publication_date>2026-07-09T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Living with Follicular Lymphoma: Counseling Patients, Evolving Treatments, and Remaining Unmet Needs]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/fda-expands-approval-for-vwd-prophylaxis-in-children-younger-than-6</loc><lastmod>2026-07-08T20:53:52.793Z</lastmod><news:news><news:publication_date>2026-07-08T20:53:52.793Z</news:publication_date>
        <news:title><![CDATA[FDA Expands Approval for VWD Prophylaxis in Children Younger Than 6]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/polygenic-risk-score-may-improve-idiopathic-pulmonary-fibrosis-risk-prediction</loc><lastmod>2026-07-08T18:38:00Z</lastmod><news:news><news:publication_date>2026-07-08T18:38:00Z</news:publication_date>
        <news:title><![CDATA[Polygenic Risk Score May Improve Idiopathic Pulmonary Fibrosis Risk Prediction]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/ebola-cases-top-1700-as-unpaid-health-workers-strike</loc><lastmod>2026-07-08T17:49:21.557Z</lastmod><news:news><news:publication_date>2026-07-08T17:49:21.557Z</news:publication_date>
        <news:title><![CDATA[Ebola Cases Top 1700 as Unpaid Health Workers Strike]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/easing-barriers-to-btk-inhibitors-in-cll-kerry-rogers-md</loc><lastmod>2026-07-08T14:27:47.094Z</lastmod><news:news><news:publication_date>2026-07-08T14:27:47.094Z</news:publication_date>
        <news:title><![CDATA[Easing Barriers to BTK Inhibitors in CLL: Kerry Rogers, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/barriers-practices-and-the-road-ahead-for-car-t-cell-therapy-in-the-community-setting-a-q-a-with-michael-byrne-do</loc><lastmod>2026-07-08T14:18:00Z</lastmod><news:news><news:publication_date>2026-07-08T14:18:00Z</news:publication_date>
        <news:title><![CDATA[Interview With Michael Byrne, DO: Barriers, Practices, and the Road Ahead for CAR T-Cell Therapy in the Community Setting]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/car-t-cell-therapy-expanding-access-and-building-community-programs-a-q-a-with-robert-richards-ms-mba</loc><lastmod>2026-07-08T14:15:00Z</lastmod><news:news><news:publication_date>2026-07-08T14:15:00Z</news:publication_date>
        <news:title><![CDATA[An Interview With Robert Richards, MS, MBA: CAR T-Cell Therapy, Expanding Access and Building Community Programs ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/community-oncology-and-car-t-cell-therapy-a-q-a-with-lucio-gordan-md</loc><lastmod>2026-07-08T13:51:06.146Z</lastmod><news:news><news:publication_date>2026-07-08T13:51:06.146Z</news:publication_date>
        <news:title><![CDATA[An Interview With Lucio Gordan, MD: Community Oncology and CAR T-Cell Therapy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/the-new-oncology-blueprint-integrating-clinical-intelligence-for-sustainable-value</loc><lastmod>2026-07-08T13:00:00Z</lastmod><news:news><news:publication_date>2026-07-08T13:00:00Z</news:publication_date>
        <news:title><![CDATA[The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/gene-therapy-could-ease-wet-amd-s-injection-burden-carl-regillo-md</loc><lastmod>2026-07-08T13:00:00Z</lastmod><news:news><news:publication_date>2026-07-08T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Gene Therapy Could Ease Wet AMD's Injection Burden: Carl Regillo, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/quest-adds-haystack-mrd-to-oncoemr-for-community-oncology</loc><lastmod>2026-07-08T13:00:00Z</lastmod><news:news><news:publication_date>2026-07-08T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Quest Adds Haystack MRD to OncoEMR for Community Oncology]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/open-access-to-anti-vegf-therapies-in-retinal-vascular-diseases</loc><lastmod>2026-07-08T12:05:00Z</lastmod><news:news><news:publication_date>2026-07-08T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Open Access to Anti-VEGF Therapies in Retinal Vascular Diseases]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/refractory-vs-exposed-how-anti-cd38-status-shapes-second-line-treatment-decisions-in-multiple-myeloma</loc><lastmod>2026-07-08T12:05:00Z</lastmod><news:news><news:publication_date>2026-07-08T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Refractory vs. Exposed: How Anti-CD38 Status Shapes Second-Line Treatment Decisions in Multiple Myeloma]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/first-relapse-in-multiple-myeloma-balancing-options-sequencing-decisions-and-patient-centered-care</loc><lastmod>2026-07-08T12:00:00Z</lastmod><news:news><news:publication_date>2026-07-08T12:00:00Z</news:publication_date>
        <news:title><![CDATA[First Relapse in Multiple Myeloma: Balancing Options, Sequencing Decisions, and Patient-Centered Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/treatment-frequency-in-retinal-vascular-diseases</loc><lastmod>2026-07-08T12:00:00Z</lastmod><news:news><news:publication_date>2026-07-08T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Treatment Frequency in Retinal Vascular Diseases]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/nonprofit-system-affiliated-hospitals-lead-in-multilingual-financial-assistance-access-erin-l-duffy-phd-mph</loc><lastmod>2026-07-07T20:00:00Z</lastmod><news:news><news:publication_date>2026-07-07T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Nonprofit, System-Affiliated Hospitals Lead in Multilingual Financial Assistance Access: Erin L. Duffy, PhD, MPH]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/inca033989-shows-potential-as-a-targeted-approach-for-myelofibrosis-with-mutant-calreticulin-claire-harrison-md</loc><lastmod>2026-07-07T20:00:00Z</lastmod><news:news><news:publication_date>2026-07-07T20:00:00Z</news:publication_date>
        <news:title><![CDATA[INCA033989 Shows Potential as a Targeted Approach for Myelofibrosis With Mutant Calreticulin: Claire Harrison, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/fda-approves-atacicept-for-iga-nephropathy</loc><lastmod>2026-07-07T18:18:12.734Z</lastmod><news:news><news:publication_date>2026-07-07T18:18:12.734Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Atacicept for IgA Nephropathy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/il-6-not-hscrp-modified-lp-a--associated-cad-risk</loc><lastmod>2026-07-07T17:45:14.706Z</lastmod><news:news><news:publication_date>2026-07-07T17:45:14.706Z</news:publication_date>
        <news:title><![CDATA[IL-6, Not hsCRP, Modified Lp(a)-Associated CAD Risk ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/agave-201-secondary-analysis-supports-bone-health-safety-of-axatilimab-in-chronic-gvhd-amandeep-salhotra-md</loc><lastmod>2026-07-07T17:30:00Z</lastmod><news:news><news:publication_date>2026-07-07T17:30:00Z</news:publication_date>
        <news:title><![CDATA[AGAVE-201 Secondary Analysis Supports Bone Health Safety of Axatilimab in Chronic GVHD: Amandeep Salhotra, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/reducing-coverage-barriers-testing-delays-could-further-improve-lung-cancer-outcomes-robert-kratzke-md</loc><lastmod>2026-07-07T17:00:00Z</lastmod><news:news><news:publication_date>2026-07-07T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Reducing Coverage Barriers, Testing Delays Could Further Improve Lung Cancer Outcomes: Robert Kratzke, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/contributor-rethinking-academic-community-partnerships-in-oncology-never-the-twain-shall-meet-</loc><lastmod>2026-07-07T16:45:17.408Z</lastmod><news:news><news:publication_date>2026-07-07T16:45:17.408Z</news:publication_date>
        <news:title><![CDATA[Contributor: Rethinking Academic-Community Partnerships in Oncology: Never the Twain Shall Meet?]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/blood-pressure-remained-stable-after-mavacamten-in-ohcm</loc><lastmod>2026-07-07T15:28:12.335Z</lastmod><news:news><news:publication_date>2026-07-07T15:28:12.335Z</news:publication_date>
        <news:title><![CDATA[Blood Pressure Remained Stable After Mavacamten in oHCM]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/hypoglossal-nerve-stimulation-linked-to-reduced-hypoxic-burden-in-osa</loc><lastmod>2026-07-07T14:25:35.479Z</lastmod><news:news><news:publication_date>2026-07-07T14:25:35.479Z</news:publication_date>
        <news:title><![CDATA[Hypoglossal Nerve Stimulation Linked to Reduced Hypoxic Burden in OSA]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/340b-drug-payment-cuts-headline-cms-proposal-to-lower-medicare-costs</loc><lastmod>2026-07-07T14:25:04.171Z</lastmod><news:news><news:publication_date>2026-07-07T14:25:04.171Z</news:publication_date>
        <news:title><![CDATA[340B Drug Payment Cuts Headline CMS Proposal to Lower Medicare Costs]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/readability-of-hospital-patient-financial-policy-documents</loc><lastmod>2026-07-07T13:00:00Z</lastmod><news:news><news:publication_date>2026-07-07T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Readability of Hospital Patient Financial Policy Documents]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/fixing-the-mental-health-system-burnout-advocacy-and-the-case-for-team-based-care</loc><lastmod>2026-06-16T12:15:00.000Z</lastmod><news:news><news:publication_date>2026-07-07T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Fixing the Mental Health System: Burnout, Advocacy, and the Case for Team-Based Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/the-ripple-effect-of-coverage-delays-patient-harm-and-preventable-crises-in-psychiatry</loc><lastmod>2026-06-16T12:15:00.000Z</lastmod><news:news><news:publication_date>2026-07-07T12:00:00Z</news:publication_date>
        <news:title><![CDATA[The Ripple Effect of Coverage Delays: Patient Harm and Preventable Crises in Psychiatry]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url></urlset>